
|Articles|October 1, 2010
Dermatology Times, Digital Edition, October 2010
EHRs, Worth the Hassle? : ‘Meaningful use’ criteria can pose high hurdle for derms Allergan Settles : Drugmaker to pay $600 million to resolve off-label marketing charges Special Report : Hair & Nails
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Improving Outcomes in Acne, Hidradenitis Suppurativa, and Vitiligo Through Treatment Advancements
2
Psychodermatology’s Role in Strengthening Therapeutic Connections
3
Day 4 Recap: Elevate-Derm Fall Conference
4
Treatment Plan Expectations and Previewing the 2026 Pipeline
5



















